Variant report
Variant | nsv916531 |
---|---|
Chromosome Location | chr13:92922404-92941030 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs189264189 | chr13:92922421-92922422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs142785516 | chr13:92922458-92922459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs528244214 | chr13:92922502-92922503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs532130241 | chr13:92922503-92922504 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs72638616 | chr13:92922549-92922550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs551913770 | chr13:92922645-92922646 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs182365630 | chr13:92922652-92922653 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs537720194 | chr13:92922676-92922677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs548083298 | chr13:92922717-92922718 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs12877870 | chr13:92922737-92922738 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs533779426 | chr13:92922756-92922757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs12874185 | chr13:92922757-92922758 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs368953982 | chr13:92922787-92922788 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs9516033 | chr13:92933005-92933006 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs539643778 | chr13:92933006-92933007 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs148396772 | chr13:92933007-92933008 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs114892054 | chr13:92933013-92933014 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
18 | rs548702596 | chr13:92933014-92933015 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs188062008 | chr13:92933022-92933023 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs568358873 | chr13:92933034-92933035 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs142519458 | chr13:92933039-92933040 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs9523586 | chr13:92933052-92933053 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs192688345 | chr13:92933058-92933059 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577575712 | chr13:92933086-92933087 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs61966609 | chr13:92933118-92933119 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs9589479 | chr13:92933130-92933131 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs576717265 | chr13:92933141-92933142 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs369545807 | chr13:92933204-92933205 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs35041708 | chr13:92933207-92933208 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs561086983 | chr13:92933222-92933223 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs574332657 | chr13:92933223-92933224 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs71427543 | chr13:92933224-92933225 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs184726909 | chr13:92933257-92933258 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs532247189 | chr13:92933259-92933260 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs552057683 | chr13:92933261-92933262 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs562303695 | chr13:92933310-92933311 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs531580352 | chr13:92933332-92933333 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs71419722 | chr13:92933342-92933343 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs9516035 | chr13:92933343-92933344 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs534049940 | chr13:92933358-92933359 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs189592062 | chr13:92933377-92933378 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs181515753 | chr13:92933381-92933382 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
43 | rs9516036 | chr13:92933387-92933388 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs9516037 | chr13:92933395-92933396 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs113279778 | chr13:92933416-92933417 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs145680938 | chr13:92933435-92933436 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs115276268 | chr13:92933436-92933437 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs9516038 | chr13:92933452-92933453 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs184601629 | chr13:92933469-92933470 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
50 | rs371225527 | chr13:92933496-92933497 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Myelofibrosis | 22110671 | CNVD |
coloboma | 21285886 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 20877625 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Developmental delay | 20808231 | CNVD |
Obesity | 20808231 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:92922400-92922800 | Enhancers | Rectal Smooth Muscle | rectum |
2 | chr13:92933000-92933800 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
3 | chr13:92933200-92933400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr13:92933200-92933800 | Active TSS | HUES6 Cell Line | embryonic stem cell |